Painful Intercourse (Dyspareunia) After Breast Cancer Treatment: What Causes It and What the Research Shows
None of that is true. You do not have to accept it. It is not something you caused. And there are real, non-hormonal options supported by published research.
This article explains exactly what is happening in the body, why breast cancer treatment so frequently causes painful intercourse, and what approaches can help. It is written for women on anastrozole (Arimidex), letrozole (Femara) and exemestane (Aromasin), as well as those who have been through chemotherapy, tamoxifen or surgical menopause.
How Common Is Painful Intercourse After Breast Cancer Treatment?
Far more common than most people realize, and far more underreported. Published research has found that dyspareunia, the clinical term for painful intercourse, was reported by more than 50% of women receiving aromatase inhibitors including anastrozole, letrozole and exemestane
- A systematic review of sexual dysfunction in breast cancer survivors found that the majority of survivors experience sexual problems in survivorship, most commonly vaginal and vulvar dryness, which directly contributes to painful intercourse
- Despite this prevalence, a 2004 survey found that 98% of midlife women had at least one sexual concern, but clinicians broached the topic only 18% of the time.
-
The burden of raising this issue is almost always left to the patient, and many women never
do. The result is unnecessary suffering for a problem that has real, addressable causes.
What Is Actually Causing the Pain?
Painful intercourse after breast cancer treatment is not psychological and it is not inevitable. It has specific physical causes that are well understood clinically.
Vaginal Atrophy and Tissue Thinning
Estrogen maintains the thickness, moisture and elasticity of vaginal tissue. When estrogen drops from aromatase inhibitor therapy, chemotherapy-induced menopause or surgical menopause, the vaginal walls thin, dry out and lose their natural flexibility. This is called vaginal atrophy. Thinned tissue is far more vulnerable to friction, tearing and pain during intercourse. Even gentle penetration can feel sharp, burning or raw.
Loss of Natural Lubrication
Estrogen also stimulates the natural lubrication that prepares the vagina for comfortable intercourse. Without adequate estrogen, that lubrication response diminishes significantly. The result is increased friction during sex, which causes both pain during and after intercourse. The less frequently intercourse occurs because of pain, the more the tissue continues to thin from lack of stimulation and blood flow, which can make the cycle progressively worse over time.
Vulvar Changes
The vulva, the external tissue surrounding the vaginal opening, is also estrogen-dependent. After breast cancer treatment, the labia may thin and shrink, the vestibule, the entry to the vagina, becomes more sensitive and fragile, and nerve proliferation in the vulvar tissue can make even light touch painful. This is sometimes called vestibulodynia and it can make penetration acutely painful even when internal vaginal tissue has improved.
Pelvic Floor Muscle Tension
When intercourse is painful, the body learns to anticipate pain. Pelvic floor muscles respond by tensing protectively, which makes penetration even more difficult and painful. Over time this can become a conditioned response that persists even after the underlying tissue issues have improved. This is why addressing painful intercourse often requires both tissue-based and muscle-based approaches together.
Why Estrogen Is Often Complicated After Breast Cancer Treatment
A 2022 Danish observational cohort study published in the Journal of the National Cancer Institute found a statistically significant increased risk of breast cancer recurrence in women who used vaginal estrogen concurrently with aromatase inhibitors.
This was one observational study and some subsequent research has not replicated the same finding across all populations. However, based on currently available evidence, most oncologists advise caution or avoidance of estrogen for women actively taking aromatase inhibitors. This is a conversation to have directly with your oncology team, who can advise based on your individual circumstances.
Non-Hormonal Options That the Research Supports
Addressing the underlying vaginal atrophy and dryness is the most important step in reducing painful intercourse. Without adequate vaginal moisture and tissue health, intercourse will continue to be painful regardless of what lubricant is used in the moment.
Hyaluronic acid is a molecule found naturally throughout the body that attracts and retains water in tissue. Research has shown that when delivered as a vaginal suppository used consistently over time, it can support vaginal tissue hydration, reduce dryness and improve tissue comfort [5,6]. A multicenter randomized controlled trial found hyaluronic acid vaginal gel produced significant improvement in vaginal dryness comparable to estriol cream, with no statistically significant difference in outcomes.
1. A 2024 randomized pilot trial found no clinically meaningful difference between vaginal hyaluronic acid and vaginal estrogen for GSM symptoms after 12 weeks
2. These findings relate to hyaluronic acid as an ingredient. As with any product, individual results may vary..
HAPure by NewLife Naturals (currently available as HA Inserts, being renamed to HAPure) contains 5mg of hyaluronic acid sodium salt. It is naturally derived, estrogen free, non-GMO and paraben free. It does not interact with estrogen receptors and is not contraindicated for women on anastrozole, letrozole or exemestane. Consult your healthcare provider before starting any new product.
A Note on Initial Sensitivity
Some women with significant vaginal atrophy may notice mild sensitivity during initial suppository use as tissue adjusts. This is common and typically improves with consistent use over several weeks. Applying a small amount of natural oil such as coconut or jojobaoil to the vaginal opening before inserting the suppository can help ease initial sensitivity. Starting with half a suppository and working up to the full amount is an approach some women find helpful. Discuss any persistent discomfort with your healthcare provider.
2. Vulvar Balms for External Tissue
Painful intercourse often involves the vulvar vestibule, the sensitive tissue at the vaginal entrance, as much as the internal vaginal canal. A clean, naturally derived vulva balm applied externally to the labia and vestibule before intercourse can help reduce friction and sensitivity at the point of entry. Applied regularly as a moisturizer between intimate activity, it also helps maintain external tissue health over time. NewLife Naturals vulva balms are formulated with certified organic ingredients including calendula and vitamin E, jojoba and moringa, and shea butter and almond oil.
3. Vaginal Lubricants During Intercourse
A lubricant used during intercourse reduces friction in the moment. It is different from a vaginal moisturizer, which is applied regularly to maintain tissue health. Both serve different purposes and both are useful. For women on breast cancer treatment, look for lubricants that are water-based or silicone-based, free from glycerin, parabens and fragrances. Oil-based lubricants are not compatible with latex condoms.
4. Pelvic Floor Physical Therapy
Pelvic floor PT is one of the most important and most underutilized interventions for painful intercourse after breast cancer treatment. A specialized pelvic floor PT addresses multiple contributors simultaneously: tissue health, muscular tension, reduced elasticity, desensitization of the vestibule and coordination of pelvic floor muscles. A systematic review of interventions for sexual dysfunction in breast cancer survivors found significant evidence for regular use of vaginal moisturizers and for pelvic floor interventions.
Ask your oncologist for a referral or search the APTA pelvic health specialist directory. Many pelvic floor PTs now offer telehealth appointments.
5. Graduated Vaginal Dilators
If penetration feels impossible because of muscle tightening or severe tissue sensitivity, graduated vaginal dilators used consistently over time can help gradually restore vaginal capacity and reduce the protective muscle tension that develops around pain. Many pelvic floor PTs incorporate dilator use into their treatment plans. This is not a device to use alone without guidance, particularly after cancer treatment.
6. Addressing the Emotional Dimension
Painful intercourse does not only affect the body. It affects how women feel about themselves, their relationships and their intimacy. Research has found that sexual counseling and educational interventions specifically targeting sexual dysfunction showed improvements across multiple aspects of sexual health in breast cancer survivors.
Bringing a partner into the conversation, working with a therapist who specializes in sexual health after cancer, or connecting with a survivorship program that addresses intimacy are all valid and valuable parts of recovery
Talking to Your Team
- "I have been experiencing painful intercourse since starting my treatment. What non hormonal options would you recommend?"
- "I have read about hyaluronic acid suppositories as a non-hormonal option for vaginal atrophy. Is that appropriate for my situation?"
- "Can you refer me to a pelvic floor physical therapist who has experience with breast cancer survivors?"